Novartis raises mid-term sales guidance, citing strong drug performance and promising pipeline, but analysts express concerns about sustaining growth beyond 2029.
Matt Gaetz withdraws as Trump's attorney general pick amid controversy over past investigations and qualifications.
Adani Group executives face expanded US indictment for alleged $250 million bribery scheme, leading to massive financial and market repercussions in India.
Novartis raises mid-term sales guidance, citing strong drug performance and promising pipeline, but analysts express concerns about sustaining growth beyond 2029.
Matt Gaetz withdraws as Trump's attorney general pick amid controversy over past investigations and qualifications.
Adani Group executives face expanded US indictment for alleged $250 million bribery scheme, leading to massive financial and market repercussions in India.